FDA approves Onivyde® as a first-line therapy for metastatic pancreatic adenocarcinoma

2024-02-28 / GlobalBio & Investment

**#FDAApproval**ExcitingnewsforPharmaEngineInc(4162.TWO)!FDAapproves#Onivyde®asafirst-linetherapyformetastaticpancreaticadenocarcinoma,markingapotentialnewstandardofcare.PharmaEngine'scollabor...

GBIHighlights

The potential of next-generation microbiome therapy in clinical applications (8th AMC)

2024-02-28 / GlobalBio & Investment

*#MicrobiomeTherapy**Canthegutmicrobiotarevolutionizecancertreatment?Insightsfromthe8thAsiaMicrobiomeConference(#AMC),heldbyIBCAcademiaSinica,NationalTaiwanUniversityHospital,and圖爾思生物科技BIOTOOLSCO.,LTD...

GBIHighlights

Chang Gung Medical Foundation teams up with Gilead Sciences to accelerate early-stage clinical trial

2024-02-28 / GlobalBio & Investment

**#ClinicalTrials**ChangGungMedicalFoundationteamsupwithGileadSciencestoaccelerateearly-stageclinicaltrials,focusingon#oncology.Thecollaborationaimstoadvanceclinicaltrialsintumorresearch,preclinicalco...

GBIHighlights

GBI Spotlight: Dr. Han-Chung Wu

2024-02-28 / GlobalBio & Investment

#GBISpotlight:Dr.Han-ChungWu(吳漢忠)MeetDr.Han-ChungWu,themanbehindthedevelopmentofprecisiontherapythroughinnovativephagedisplaytechnology.AstheDirectorofBioTrecatNBRP,AcademiaSinica,heisawell-knownfigur...

GBIHighlights

Meet David Lee, the visionary founder and CEO of Singular Wings Medical

2024-02-28 / GlobalBio & Investment

**#Meet#StartupCEOs**MeetDavidLee(李維中),thevisionaryfounderandCEOofSingularWingsMedical.Fromtheelectronicsindustrytoentrepreneurship,hemerges#healthcarewith#electronics,craftinginnovativesolutionsforme...

GBIHighlights

Merck's Keytruda Leads 2023 Sales!

2024-02-28 / GlobalBio & Investment

**Merck'sKeytrudaLeads2023Sales!**Merck'sKeytrudaemergesasthetop-sellingdrugof2023,amassinganimpressive$25billioninsales.MerckCFOCarolineLitchfieldattributesKeytruda'ssurgein2023torecentap...

GBIHighlights

TBMC partners with U.S. firm National Resilience, Inc. for advanced bioprocessing

2024-02-28 / GlobalBio & Investment

**ExcitingNews!TaiwanBio-ManufacturingCorporation(#TBMC),the‘biotechTSMC,’partnerswithU.S.firmNationalResilience,Inc.foradvancedbioprocessing.ChairmanMichelChu(瞿志豪)outlinesaglobalapproachf...

GBIHighlights

AnBogen Therapeutics hits a milestone: completes USD 12.5M Series A funding round!

2024-02-28 / GlobalBio & Investment

**AnBogenTherapeuticshitsamilestone:completesUSD12.5MSeriesAfundinground!**InastrategicmoveledbyCDIBCapitalInternationalCorporation,AnBogenTherapeuticsproudlyannouncesthesuccessfulclosureofitsSeriesAf...

GBIHighlights

Revolutionizing Antibiotics: Xtraordinary Discovery by NCHU team!

2024-02-28 / GlobalBio & Investment

*RevolutionizingAntibiotics:XtraordinaryDiscoverybyNationalChungHsingUniversity(#NCHU)team!**NCHUresearchersmadeagroundbreakingdiscoveryinantibioticdevelopment.Theyfoundanucleotidesignalingmoleculetha...

GBIHighlights

EirGenix, Inc. and Sartorius delves into critical aspects such as sterile filtration

2024-02-28 / GlobalBio & Investment

**MasteringQualityAssurance!**SartoriusTaiwanelevatesproductqualitythroughrobustfiltrationsystemtesting.RZLin,aSartoriusTechSpecialist,underscoresthecrucialroleofQualityRiskManagement(#QRM)inmaintaini...

GBIHighlights Patent Genomics

Personal Genomics secures victory in the patent battle

2024-01-25 / GlobalBio & Investment

ExcitingNews!CongratulationstoPersonalGenomicsforsecuringvictoryinthepatentbattle!TheU.S.AppealsCourtdismissedPacificBiosciences'appealonJanuary9,upholdingtheoriginaldecisionbytheU.S.PatentTrialan...

GBIHighlights Healthcare MedicalTech

Globalbio magazine volume 112

2024-01-25 / GlobalBio & Investment

Involume112,Globalbiomagazinedivesintothenutsandboltsofimplementinginnovativemedicaltech. Breakingthroughthebarriersfromresearchtoclinicaltrialsisjustthestart,buttherealchallengekicksinaftervalidation...